Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-02-08

FDA Approved: DISOPYRAMIDE PHOSPHATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for disopyramide phosphate from Teva Pharmaceuticals USA, Inc., indicating an approved update to its regulatory stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DISOPYRAMIDE PHOSPHATE (Disopyramide Phosphate)

Snippet

SUPPL AP for DISOPYRAMIDE PHOSPHATE (DISOPYRAMIDE PHOSPHATE)